Study details
Enrolling now
Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
Stanford University
NCT IDNCT06080074ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
50
Study length
about 2.5 years
Ages
0–16
Locations
5 sites in CA, NC, NY +2
About this study
This trial is testing a treatment called Cardiohelp, which is a type of ECMO (extracorporeal membrane oxygenation) device used to help children with severe heart failure. The goal is to see if this device is safe and effective for these young patients.
Based on ClinicalTrials.gov records.
What participants do
- 1.Use Cardiohelp device (VA-ECMO)
PhasePhase 2
DrugBivalirudin
Routeinjection
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low9%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
bivalirudin, heparin
Drug routes
injection (Injection), injection
Endpoints
Secondary: Incidence of all serious adverse events
Body systems
Cardiology / Heart